1. Home
  2. GEO vs ELVN Comparison

GEO vs ELVN Comparison

Compare GEO & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geo Group Inc (The) REIT

GEO

Geo Group Inc (The) REIT

HOLD

Current Price

$26.82

Market Cap

3.9B

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$41.64

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEO
ELVN
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.2B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GEO
ELVN
Price
$26.82
$41.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
$39.00
★ $73.92
AVG Volume (30 Days)
★ 2.0M
1.2M
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 727.27
3.17
EPS
★ 0.65
N/A
Revenue
★ $2,263,420,000.00
N/A
Revenue This Year
$13.78
N/A
Revenue Next Year
$8.73
N/A
P/E Ratio
$42.51
★ N/A
Revenue Growth
★ 3.85
N/A
52 Week Low
$12.51
$14.79
52 Week High
$33.17
$62.32

Technical Indicators

Market Signals
Indicator
GEO
ELVN
Relative Strength Index (RSI) 33.22 40.50
Support Level $22.29 $38.58
Resistance Level $32.56 $43.05
Average True Range (ATR) 1.38 1.90
MACD -0.43 0.49
Stochastic Oscillator 10.84 47.72

Price Performance

Historical Comparison
GEO
ELVN

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: